Eighteen patients had anti‐AGO antibodies, 48 had anti‐FGFR3 antibodies, and 14 had an autoimmune disease without detectable anti‐AGO or FGFR3 antibodies. This evidence concerns the gene FGFR3 and autoimmune disease.